MANCINI, ILARIA
MANCINI, ILARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
2021 M.T. Pagliari, A. Cairo, M. Boscarino, I. Mancini, E. Pappalardo, P. Bucciarelli, I. Martinelli, F.R. Rosendaal, F. Peyvandi
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura
2021 C. Bichard, I. Mancini, P. Agosti, P. De Leo, A. Artoni, M. Capecchi, S.M. Trisolini, C. Fozza, F. Peyvandi
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge
2021 A. Tripodi, S.C. Rossi, M. Clerici, G. Merati, E. Scalambrino, I. Mancini, L. Baronciani, M. Boscarino, V. Monzani, F. Peyvandi
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis
2020 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, L. Barcella, A. Falanga, F. Peyvandi
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-Tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age
2020 P. Agosti, I. Mancini, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolin, L. Facchini, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura
2020 P. Agosti, I. Mancini, F. Gianniello, P. Bucciarelli, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolini, L. Facchini, C. Carbone, F. Peyvandi
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians
2020 I. Mancini, E. Giacomini, S. Pontiggia, A. Artoni, B. Ferrari, E. Pappalardo, R. Gualtierotti, S.M. Trisolini, S. Capria, L. Facchini, K. Codeluppi, E. Rinaldi, D. Pastore, S. Campus, C. Caria, A. Caddori, D. Nicolosi, G. Giuffrida, V. Agostini, U. Roncarati, C. Mannarella, A. Fragasso, G.M. Podda, S. Birocchi, A.M. Cerbone, A. Tufano, G. Menna, M. Pizzuti, M. Ronchi, A. De Fanti, S. Amarri, M. Defina, M. Bocchia, S. Cerù, S. Gattillo, F.R. Rosendaal, F. Peyvandi
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
2020 M. Capecchi, C. Mocellin, C. Abbruzzese, I. Mancini, D. Prati, F. Peyvandi
Lombardy network for the study and treatment of patients undergoing apheresis
2020 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, L. Barcella, A. Falanga, F. Peyvandi
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
2019 C. Valsecchi, M. Mirabet, I. Mancini, M. Biganzoli, L. Schiavone, S. Faraudo, D. Mane-Padros, D. Giles, J. Serra-Domenech, S. Blanch, S.M. Trisolini, L. Facchini, E. Rinaldi, F. Peyvandi
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series
2019 S. Arcudi, B. Ferrari, S. Pontiggia, A. Tufano, A. Artoni, I. Mancini, F. Peyvandi
Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: The role of mycophenolate mofetil
2019 F. Fioredda, E. Cappelli, A. Mariani, A. Beccaria, E. Palmisani, A. Grossi, I. Ceccherini, R. Vene, C. Micalizzi, M. Calvillo, F. Pierri, I. Mancini, F. Peyvandi, F. Corsolini, C. Dufour, M. Miano
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura
2019 B. Ferrari, A. Cairo, M. Pagliari, I. Mancini, S. Arcudi, F. Payvandi
Acquired Thrombotic Thrombocytopenic Purpura Occurring in Advanced Age : Impact of a Delayed Onset on Disease Expression
2019 P. Agosti, I. Mancini, S. Pontiggia, B. Ferrari, M. Biganzoli, A. Artoni, S.M. Trisolini, L. Facchini, C. Caria, F. Peyvandi
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
2018 E. Roose, G. Vidarsson, K. Kangro, O.J.H.M. Verhagen, I. Mancini, L. Desender, I. Pareyn, N. Vandeputte, A. Vandenbulcke, C. Vendramin, A. Schelpe, J. Voorberg, M. Azerad, L. Gilardin, M. Scully, D. Dierickx, H. Deckmyn, S.F. De Meyer, F. Peyvandi, K. Vanhoorelbeke